Bumper Offer - Urjas oil Just @ Rs. 1
NC Derm Plus is an ayurvedic medicine The correct dosage of NC Derm Plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
NC Derm Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when NC Derm Plus is used -
Moderate
Mild
Is the use of NC Derm Plus safe for pregnant women?
Pregnant women may experience moderate side effects from NC Derm Plus. It is best to stop taking NC Derm Plus immediately and inform your doctor if you notice any discomfort.
Is the use of NC Derm Plus safe during breastfeeding?
NC Derm Plus does not show any harmful effects in lactating women.
What is the effect of NC Derm Plus on the Kidneys?
NC Derm Plus is completely safe for kidneys.
What is the effect of NC Derm Plus on the Liver?
NC Derm Plus is completely safe for the liver.
What is the effect of NC Derm Plus on the Heart?
Using NC Derm Plus does not have any harmful effects on the heart.
NC Derm Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take NC Derm Plus unless your doctor advises you to do so -
Is this NC Derm Plus habit forming or addictive?
No, there is no any evidence that NC Derm Plus is addictive.
Interaction between Food and NC Derm Plus
It is safe to take NC Derm Plus with food.
Interaction between Alcohol and NC Derm Plus
Consuming limited amounts of alcohol while taking NC Derm Plus does not cause any harmful effects. But it is best to observe caution.
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vusion® (miconazole nitrate, zinc oxide, and white petrolatum)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vusion® (miconazole nitrate, zinc oxide, and white petrolatum)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
